scholarly journals An increase in the number of mumps cases in the Czech Republic, 2005-2006

2008 ◽  
Vol 13 (16) ◽  
Author(s):  
N Boxall ◽  
M Kubínyiová ◽  
V Príkazský ◽  
C Beneš ◽  
J Cástková
Keyword(s):  
Czech Republic ◽  
Incidence Rate ◽  
Vaccination Programme ◽  
Prevention And Control ◽  
Control Strategies ◽  
Age Group ◽  
The Czech Republic ◽  
Mumps Vaccine ◽  
Target Prevention ◽  
And Control

The Czech Republic has had a two-dose measles, mumps and rubella (MMR) vaccination programme since 1987. The last outbreak of mumps was reported in 2002, but an increase in the number of mumps cases was observed in 2005, starting in October that year. We analysed routinely collected surveillance data from 1 January 2005 to 30 June 2006 to show the magnitude of the increase and describe the most affected groups in order to better target prevention and control strategies. In the 18-month period examined, 5,998 cases of mumps were notified, with a peak incidence in May 2006. No deaths were recorded, but 21% of cases were hospitalised. Incidence was lowest in the Plzeň region (1.9/100,000) and highest in Zlín (118.6/100,000). There were more male (61.8%) than female cases. The age of the cases ranged from 0 to 80 years. The highest incidence rate was observed in the age group of 15 to 19 years, in which 87% of cases had received two doses of mumps vaccine. The average age of unvaccinated cases was 22.9 years, while for cases vaccinated with two doses it was 14.5 years. Although vaccine effectiveness could not be calculated from the data available, possible reasons for highly-vaccinated cases occurring are discussed.

scholarly journals Tuberculosis in Poland in 2017

2019 ◽  
pp. 211-226 ◽  
Author(s):  
Maria Korzeniewska- Koseła
Keyword(s):  
Pulmonary Tuberculosis ◽  
Incidence Rate ◽  
Prevention And Control ◽  
Incidence Rates ◽  
Age Group ◽  
Pulmonary Tb ◽  
Mdr Tb ◽  
Tuberculosis In Children ◽  
And Control ◽  
The Eu

AIM OF THE STUDY. To evaluate the main features of TB epidemiology in 2017 in Poland and to compare with the situation in the EU/EEA countries. METHODS. Analysis of case- based data on TB patients from National TB Register, data on anti-TB drug susceptibility testing results in cases notified in 2017, data from National Institute of Public Health- National Institute of Hygiene on cases of tuberculosis as AIDS-defining disease, data from Central Statistical Office on deaths from tuberculosis based on death certificates, data from ECDC report „European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2019-2017 data. Stockholm: European Centre for Disease Prevention and Control, 2019”. RESULTS. In 2017, 5 787 TB cases were reported in Poland. The incidence rate was 15.1 cases per 100 000, with large variability between voivodeships from 8.9 to 21.9 per 100 000. The mean annual decrease of TB incidence in 2013-2017 was 4.2%. In 2017, 5127 cases were newly diagnosed with no history of previous treatment i.e. 13.3 per 100 000. 660 cases i.e. 1.7 per 100 000 – 11.4% of all registered subjects were previously treated for tuberculosis. In 2017, the number of all pulmonary tuberculosis cases was 5 531 i.e. 14.4 per 100 000. Pulmonary cases represented 95.6% of all TB cases. In 2017, 256 extrapulmonary TB cases were found. In the whole country there were 68 pediatric cases of tuberculosis. TB in children represented 1.2% of all cases notified in Poland in 2017. The incidence rates of tuberculosis were growing along with the age group from 1.2 per 100 000 among children to 25.6 per 100 000 among subjects in the age group 45-64 years (the highest incidence rate). In 2017, the incidence rate in the age group ≥65 years was 22.6 per 100 000. The TB incidence among men i.e. 22.2 per 100.000 was 2.4 times higher than among women i.e. 8,4 per 100 000. The biggest difference in the TB incidence between the two sex groups occurred in persons aged 45 to 49 years – 36.1 vs. 8.1 and in age group 55- 59 years – 45.2 vs. 10.7. The TB incidence in rural population was lower than in urban, respectively 14.2 per 100.000 and 15.6 per 100 000. The number of all registered culture positive TB cases was 4 179. Pulmonary tuberculosis was bacteriologically confirmed in 4 057 subjects. Culture-confirmed cases represented 72.2% of all TB cases and 73.4% of all pulmonary TB cases. The number of smear-positive pulmonary TB cases reported in 2017 was 2 472 i.e. 6.4 per 100 000 accounting for 44.7% of all pulmonary TB cases and 60.9% of culture confirmed pulmonary TB cases.. TB was AIDS indicative disease in 16 subjects. In all patients with tuberculosis in Poland in 2017 there were 44 cases with MDR-TB (among them 12 foreigners) and 85 patients with resistance to isoniazid only, representing respectively 1.2% and 2.2% of cases with known DST results (DSTs were available in 90.5% of all cultureconfirmed TB cases). In 2017, there were 108 patients of foreign origin among all cases of tuberculosis in Poland. TUBERCULOSIS MORTALITY. There were 543 deaths due to tuberculosis reported in 2016 – 1.4 per 100 000; 526 people died from pulmonary and 17 from extrapulmonary tuberculosis. Mortality among males – 2.2 per 100 000 – was 3.7 X higher than among females – 0.6. 37.9% of all TB deaths were cases 65 years old and older – 3.3 per 100 000. In 2016, there was one death from tuberculosis in children and no deaths in adolescents. In 2016, tuberculosis represented 0.14% of total mortality in Poland and 28.1% of mortality from infectious diseases. CONCLUSIONS. In 2017, the incidence of tuberculosis in Poland was lower than in 2016. Despite a continuous decline it is still higher than the average in the EU/EEA countries. The highest incidence rates were observed in older age groups. The incidence in males was more than 2 times higher than in females. The impact of migration on the characteristics of tuberculosis in Poland is not substantial. In Poland, tuberculosis in children, tuberculosis in persons infected with HIV and MDR-TB is less common than the average in the EU/EEA countries.

Human anthrax in Turkey: A ten years’ experience (2009–2018)

2020 ◽  
pp. 004947552096954
Author(s):  
Seher Topluoglu ◽  
Dilber Aktas ◽  
Bekir Celebi ◽  
Fatih Kara ◽  
Mehmet Doganay ◽  
...  
Keyword(s):  
Incidence Rate ◽  
Human Disease ◽  
Prevention And Control ◽  
Control Programme ◽  
Large Animal ◽  
Age Group ◽  
National Surveillance ◽  
Notifiable Disease ◽  
Collaborative Control ◽  
And Control

Anthrax is a notifiable disease in Turkey. In order to control the human disease, animal foci are being monitored and prevention and control activities are being implemented by the Ministry of Health in coordination with the Ministry of Agriculture and Forestry. The objective of our study was to evaluate the national surveillance data and control activities in the last decade. A total of 1174 anthrax cases and 9 deaths have been reported. Anthrax was frequent in eastern provinces and in big cities where large animal movements were significant. The incidence rate was 1.5 times higher in males than in females. The disease was more common in the 30–64 age group. The number of cases increased in the summer and autumn seasons. Human anthrax is still being reported though in decreasing numbers in Turkey. A collaborative control programme continues to be needed.

scholarly journals Tuberculosis in Poland in 2018

2020 ◽  
pp. 239-257
Author(s):  
Maria Korzeniewska-Koseła
Keyword(s):  
Disease Prevention ◽  
Pulmonary Tuberculosis ◽  
Incidence Rate ◽  
Prevention And Control ◽  
Incidence Rates ◽  
Age Group ◽  
Pulmonary Tb ◽  
Mdr Tb ◽  
And Control ◽  
The Eu

AIM OF THE STUDY. To evaluate the main features of tuberculosis (TB) epidemiology in 2018 in Poland and to compare with the situation in the EU/EEA countries. METHODS. Analysis of case- based data on TB patients from National TB Register, data on anti-TB drug susceptibility testing results in cases notified in 2018, data from National Institute of Public Health- National Institute of Hygiene on HIV-positive subjects for whom TB was an AIDS-defining disease, data from Central Statistical Office on deaths from tuberculosis based on death certificates, data from the report „ European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2020- 2018 data. Stockholm: European Centre for Disease Prevention and Control, 2020”. RESULTS. In 2018, 5487 TB cases were reported in Poland. The incidence rate was 14.3 cases per 100000, with large variability between voivodeships from 7.3 to 23.4 per 100 000. The mean annual decrease of TB incidence in 2014- 2018 was 3.8%. In 2018, 4852 cases were newly diagnosed with no history of previous treatment i.e. 12.6 per 100 000. 635 cases i.e. 1.7 per 100 000 – 11.6% of all registered subjects were previously treated for tuberculosis. In 2018, the number of all pulmonary tuberculosis cases was 5224 i.e. 13.7 per 100000. Pulmonary cases represented 95.2% of all TB cases. In 2018, 243 extrapulmonary TB cases were found i.e. 0.6 per 100 000. In the whole country there were 52 pediatric cases of tuberculosis. TB in children represented 0.9% of all cases notified in Poland in 2018. The incidence rates of tuberculosis were growing along with the age group from 0.9 per 100 000 among children to 24.7 per 100 000 among subjects in the age group 45-64 years (the highest incidence rate). In 2018, the incidence rate in the age group ≥65 years was 21.3 per 100 000. The TB incidence among men i.e. 21.0 per 100 000 was 2.6 times higher than among women i.e. 8.0 per 100 000. The biggest difference in the TB incidence between the two sex groups occurred in persons aged 55 to 59 years – 44.9 vs. 9.8 and in age group 60- 64 years – 43.7 vs. 10.2. The TB incidence in rural population was lower than in urban, respectively 13.4 per 100 000 and 14.9 per 100 000. The number of all registered culture positive TB cases was 4075. Pulmonary tuberculosis was bacteriologically confirmed in 3935 subjects. Cases confirmed by culture represented 74.3% of all TB cases and 75.3% of all pulmonary TB cases. The number of smear-positive pulmonary TB cases reported in 2018 was 2324 i.e. 6.1 per 100 000 accounting for 44.3% of all pulmonary TB cases and 59.1% of pulmonary TB cases confirmed by culture. In all patients with tuberculosis in Poland in 2018 there were 48 cases with MDR-TB (among them 14 foreigners) and 83 patients with resistance to isoniazid only, representing respectively 1.3% and 2.2% of cases with known DST results (DSTs were available in 90.7% of all culture-confirmed TB cases). In 2018, there were 97 patients of foreign origin among all cases of tuberculosis in Poland. TB was AIDS-indicative disease in 14 subjects with HIV co-infection. There were 490 deaths due to tuberculosis reported in 2017 – 1.3 per 100 000; 468 people died from pulmonary and 22 from extrapulmonary tuberculosis. Mortality among males – 2.1 per 100 000 – was 3.6 X higher than among females – 0.5. 40.2% of all TB deaths were cases 65 years old and older – 3.1 per 100 000. In 2017, there was no death from tuberculosis in children and no deaths in adolescents. In 2017, tuberculosis represented 0.1% of total mortality in Poland and 25.4% of mortality from infectious and parasitic diseases. CONCLUSIONS. In 2018, the incidence of tuberculosis in Poland was lower than in 2017. Despite a continuous decline it is still higher than the average in the EU/EEA countries. The highest incidence rates were observed in older age groups. The participation of pediatric cases is smaller than average in the EU/EEA countries. The incidence in males was more than 2 times higher than in females. The impact of migration on the characteristics of tuberculosis in Poland is not substantial. In Poland, MDR-TB is less common than the average in the EU/EEA countries.

Effective infection prevention and control strategies in a large accredited psychiatric facility in Singapore

2020 ◽  
Author(s):  
Daniel Poremski ◽  
Sandra Henrietta Subner ◽  
Grace Lam Fong Kin ◽  
Raveen Dev Ram Dev ◽  
Mok Yee Ming ◽  
...  
Keyword(s):  
Mental Health ◽  
Prevention And Control ◽  
Infection Prevention ◽  
Control Strategies ◽  
Infection Prevention And Control ◽  
Psychiatric Facility ◽  
Essential Services ◽  
Community Transmission ◽  
And Control

The Institute of Mental Health in Singapore continues to attempt to prevent the introduction of COVID-19, despite community transmission. Essential services are maintained and quarantine measures are currently unnecessary. To help similar organizations, strategies are listed along three themes: sustaining essential services, preventing infection, and managing human and consumable resources.

High Rates of Streptococcus Agalactiae Clindamycin and Erythromycin Resistance in Vietnamese Pregnant Women

2021 ◽  
Author(s):  
Vu Du ◽  
Pham Thai Dung ◽  
Nguyen Linh Toan ◽  
Can Mao ◽  
Nguyen Thanh Bac ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Antimicrobial Susceptibility ◽  
Prevention And Control ◽  
Control Strategies ◽  
Geographic Area ◽  
Resistance Rate ◽  
Antibiotics Resistance ◽  
Erythromycin Resistance ◽  
Antimicrobial Susceptibility Pattern ◽  
And Control

Abstract Background Group B streptococcus (GBS) is a leading cause of morbidity and mortality in newborns. Maternal GBS colonization rates vary depending on geographic area, ethnic and social conditions worldwide. Many studies suggested the continuous surveillance of GBS to provide data to guide decision-making and planning prevention and control strategies. Here, we report the rate and the antimicrobial susceptibility pattern of GBS from Vietnamese pregnant women over 5 year period. Methods We worked with 3863 Vietnamese pregnant women at < 37 weeks of gestation at the National Hospital of Obstetrics and Gynecology, Hanoi, Vietnam from Jan 2016 to Dec 2020. The data were recorded and retrieved from the computerized laboratory database. GBS was identified according to the American Society for Microbiology’s guidelines. Antimicrobial susceptibility was tested by the VITEK 2 system or E-test strips. The results were calculated according to the MIC breakpoints recommended by the Clinical and Laboratory Standards Institute. Results The positivity for GBS was 8.02% (310/3863) and the highest resistance rate was to tetracycline 89.66% (234/261), followed by 76.23% (202/265) for erythromycin, 58.21% (156/268) for clindamycin. The multidrug-resistance rate was 59.19% (161/272), and 8.46% (23/272) of isolates were resistant to 6 to 7 of the 12 antibiotics. Resistance to clindamycin in the absence of erythromycin resistance was found in 6/272 (2.2%) samples. The resistance rate to clindamycin was significantly increased (p < 0.01) over the time study period. Nevertheless, all isolates were sensitive to penicillin, ampicillin, ceftriaxone, cefotaxime, quinupristin/dalfopristin, and vancomycin. Conclusion Our results indicate that penicillin and ampicillin are currently the drugs of choice for the prevention and treatment of GBS-related diseases for Vietnamese pregnant women. However, antibiotic resistance to erythromycin and clindamycin was high. Thus, it reinforces the need for continuous surveillance of GBS to provide data to guide planning prevention and control strategies.

scholarly journals Waterborne microorganisms and biofilms related to hospital infections: strategies for prevention and control in healthcare facilities

2015 ◽  
Vol 14 (1) ◽  
pp. 52-67 ◽  
Author(s):  
Raquel Vannucci Capelletti ◽  
Ângela Maria Moraes
Keyword(s):  
Nosocomial Infections ◽  
Distribution System ◽  
Prevention And Control ◽  
Water Distribution ◽  
Water Distribution System ◽  
Control Strategies ◽  
Hospital Infections ◽  
Healthcare Facilities ◽  
Microbiological Control ◽  
And Control

Water is the main stimulus for the development of microorganisms, and its flow has an important role in the spreading of contaminants. In hospitals, the water distribution system requires special attention since it can be a source of pathogens, including those in the form of biofilms often correlated with resistance of microorganisms to various treatments. In this paper, information relevant to cases of nosocomial infections involving water circuits as a source of contaminants is compiled, with emphasis on the importance of microbiological control strategies to prevent the installation, spreading and growth of microorganisms in hospitals. An overview of the worldwide situation is provided, with emphasis on Brazilian hospitals. Different approaches normally used to control the occurrence of nosocomial infections due to waterborne contaminants are analyzed, and the use of the polysaccharide chitosan for this specific application is briefly discussed.

scholarly journals Vaccine impact and effectiveness of meningococcal serogroup ACWY conjugate vaccine implementation in the Netherlands: a nationwide surveillance study

2021 ◽  
Author(s):  
Milou Ohm ◽  
Susan J M Hahné ◽  
Arie van der Ende ◽  
Elizabeth A M Sanders ◽  
Guy A M Berbers ◽  
...  
Keyword(s):  
The Netherlands ◽  
Incidence Rate ◽  
Vaccination Programme ◽  
Screening Method ◽  
Age Groups ◽  
Incidence Rates ◽  
Age Group ◽  
Mass Campaign ◽  
Conjugate Vaccination ◽  
The Impact

Abstract Background In response to the recent serogroup W invasive meningococcal disease (IMD-W) epidemic in the Netherlands, meningococcal serogroup C (MenC) conjugate vaccination for 14-month-olds was replaced with a MenACWY conjugate vaccination, and a mass campaign targeting 14-18 year-olds was executed. We investigated the impact of MenACWY vaccination implementation in 2018-2020 on incidence rates and estimated vaccine effectiveness (VE). Methods We extracted all IMD cases diagnosed between July 2014 and December 2020 from the national surveillance system. We calculated age group-specific incidence rate ratios by comparing incidence rates before (July 2017-March 2018) and after (July 2019-March 2020) MenACWY vaccination implementation. We estimated VE in vaccine-eligible cases using the screening method. Results Overall, IMD-W incidence rate lowered by 61% (95%CI 40-74). It declined by 82% (95%CI 18-96) in vaccine-eligible age group (15-36 month-olds and 14-18 year-olds) and by 57% (95%CI 34-72) in vaccine non-eligible age groups. VE was 92% (95%CI -20-99.5) against IMD-W vaccine-eligible toddlers. No IMD-W cases were reported in vaccine-eligible teenagers after the campaign. Conclusions The MenACWY vaccination programme was effective in preventing IMD-W in the target population. The IMD-W incidence reduction in vaccine non-eligible age groups may be caused by indirect effects of the vaccination programme. However, disentangling natural fluctuation from vaccine-effect was not possible. Our findings encourage the use of toddler- and teenager MenACWY vaccination in national immunization programmes especially when implemented together with a teenager mass campaign during an epidemic.

scholarly journals Knowledge Enhancement about COVID-19 Prevention on Community with Webinar Program

2021 ◽  
Vol 5 (1) ◽  
pp. 103
Author(s):  
Ratih Damayanti
Keyword(s):  
Community Participation ◽  
Prevention And Control ◽  
P Value ◽  
Public Knowledge ◽  
Age Group ◽  
Community Groups ◽  
Public Facilities ◽  
Knowledge Enhancement ◽  
And Control ◽  
At Home

COVID-19 is increasingly difficult to control. There is evidence of an increase in cases during the beginning of December. There needs to be community participation in prevention and control efforts anywhere (including at home, public facilities and workplaces). Webinars are a method that can be used during a pandemic to increase public knowledge. In this activity, the results showed that some of the participants were female in the age group less than 30 years old with status as students. There was a significant increase in knowledge (p-value = 0.000) of community groups who were provided with counseling through webinars of 9.17 points. It is necessary to expand the reach of people who get counseling through webinars so that information or knowledge about the prevention and handling of COVID-19 can be widely spread throughout Indonesia. 

Sign in / Sign up

Export Citation Format

Share Document